Nasrat Hakim
Chief Executive Officer bei ELITE PHARMACEUTICALS, INC.
Vermögen: 34 Mio $ am 31.03.2024
Profil
Nasrat A.
Hakim is the founder of Mikah Pharma LLC, which was founded in 2009.
He held the title of President & Chief Executive Officer from 2009 to 2017.
He is currently the Chairman, President & Chief Executive Officer at Elite Pharmaceuticals, Inc. since 2013.
In his former positions, he was the Executive Director-Quality Unit at Theratechnologies, Inc. from 1997 to 2004, the International Vice President-Quality Assurance at Actavis, Inc. from 2004 to 2013, the Global VP-Quality & Regulatory Compliance at Zoetis Products LLC from 2004 to 2007, and the Vice President-Quality at Alexza Pharmaceuticals, Inc. He also held the position of Global VP-Quality & Regulatory Compliance at Alpharma LLC.
Mr. Hakim obtained his undergraduate and graduate degrees from California State University-Sacramento in 1989 and his graduate degree from St. Thomas University School of Law in 2006.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ELITE PHARMACEUTICALS, INC.
21,77% | 29.03.2024 | 221 572 397 ( 21,77% ) | 34 Mio $ | 31.03.2024 |
Aktive Positionen von Nasrat Hakim
| Unternehmen | Position | Beginn |
|---|---|---|
| ELITE PHARMACEUTICALS, INC. | Chief Executive Officer | 02.08.2013 |
Ehemalige bekannte Positionen von Nasrat Hakim
| Unternehmen | Position | Ende |
|---|---|---|
Mikah Pharma LLC
 Mikah Pharma LLC Pharmaceuticals: MajorHealth Technology Mikah Pharma LLC manufactures pharmaceutical drugs. The company was founded by Nasrat A. Hakim in 2009 and is headquartered in Hillsborough, NJ. | Chief Executive Officer | 01.05.2017 |
Actavis, Inc.
 Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | 01.01.2013 |
Zoetis Products LLC
 Zoetis Products LLC Pharmaceuticals: MajorHealth Technology Zoetis Products LLC engaged in the manufacturing of pharmaceutical products. The company was founded in 1975 and was headquartered in Florham Park, NJ. | Compliance Officer | 01.01.2007 |
| THERATECHNOLOGIES INC. | Corporate Officer/Principal | 01.01.2004 |
| Alpharma LLC | Corporate Officer/Principal | - |
Ausbildung von Nasrat Hakim
| California State University-Sacramento | Graduate Degree |
| St. Thomas University School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ELITE PHARMACEUTICALS, INC. | Health Technology |
| THERATECHNOLOGIES INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | Health Technology |
Zoetis Products LLC
Zoetis Products LLC Pharmaceuticals: MajorHealth Technology Zoetis Products LLC engaged in the manufacturing of pharmaceutical products. The company was founded in 1975 and was headquartered in Florham Park, NJ. | Health Technology |
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexza Pharmaceuticals, Inc. is a pharmaceutical company. It focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni in 2000 and is headquartered in Mountain View, CA. | Health Technology |
Mikah Pharma LLC
Mikah Pharma LLC Pharmaceuticals: MajorHealth Technology Mikah Pharma LLC manufactures pharmaceutical drugs. The company was founded by Nasrat A. Hakim in 2009 and is headquartered in Hillsborough, NJ. | Health Technology |
| Alpharma LLC |
